Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function

Arthritis and Rheumatism

Volumn 64, Issue 10, 2012, Pages 3313-3323

  Van De Loo, Fons A J ^a   Veenbergen, Sharon ^a   Van Den Brand, Ben ^a   Bennink, Miranda B ^a   Blaney Davidson, Esmeralda ^a   Arntz, Onno J ^a   Van Beuningen, Henk M ^a   Van Der Kraan, Peter M ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ARTICLE; CARTILAGE CELL; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; FEMUR NECK FRACTURE; HUMAN; HUMAN CELL; INJURY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; VIRAL GENE DELIVERY SYSTEM;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CATTLE; CELL LINE; CHONDROCYTES; FEMALE; HUMANS; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEOGLYCANS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84869006582     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34529     Document Type: Article

References (53)

1. Van Den Berg WB, van de Loo FA, Zwarts WA, Otterness IG. Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis 1988; 47: 855-63.
2. Van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, Van Den Berg WB. Role of interleukin-1, tumor necrosis factor -, and interleukin- 6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995; 38: 164-72.
3. Van de Loo FA, Veenbergen S, Van Den Berg WB. Targeting growth factors in arthritis: a rationale for restoring the IGF-1 response in chondrocytes. Curr Rheumatol Rev 2008; 4: 266-76.
4. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224: 265-83.
5. Pass C, MacRae VE, Ahmed SF, Farquharson C. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem Funct 2009; 27: 119-27.
6. Smeets RL, Veenbergen S, Arntz OJ, Bennink MB, Joosten LA, Van Den Berg WB, et al. A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis Rheum 2006; 54: 1518-28.
7. O'Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity 2008; 28: 477-87. (Pubitemid 351467044)
8. Veenbergen S, Bennink MB, de Hooge AS, Arntz OJ, Smeets RL, Van Den Berg WB. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis. Arthritis Rheum 2008;58: 3742-52.
9. Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, Arntz OJ, et al. A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis. Ann Rheum Dis 2011; 70: 2167-75.
10. De Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, et al. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum 2004; 50: 2014-23. (Pubitemid 38725114)
11. Loeser RF, Shanker G, Carlson CS, Gardin JF, Shelton BJ, Sonntag WE. Reduction in the chondrocyte response to insulinlike growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 2000; 43: 2110-20.
12. Salminen A, Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-B signaling. Cell Signal 2010;22: 537-7.
13. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
14. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
16. Geurts J, Vermeij EA, Pohlers D, Arntz OJ, Kinne RW, Van Den Berg WB, et al. A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts. Ann Rheum Dis 2011; 70: 1311-9.
17. De Andres MC, Imagawa K, Hashimoto K, Gonzalez A, Goldring MB, Roach HI, et al. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun 2011; 407: 54-9.
18. Mizui Y, Yamazaki K, Kuboi Y, Sagane K, Tanaka I. Characterization of 5-flanking region of human aggrecanase-1 (ADAMTS4) gene. Mol Biol Rep 2000; 27: 167-73.
19. Liacini A, Sylvester J, Li WQ, Zafarullah M. Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes. Arthritis Res Ther 2005;7:R777-83.
20. Ehlting C, Haussinger D, Bode JG. Sp3 is involved in the regulation of SOCS3 gene expression. Biochem J 2005;387(Pt 3): 737-45. (Pubitemid 40685708)
21. Ghayor C, Chadjichristos C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, et al. Sp3 represses the Sp-1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J Biol Chem 2001; 276: 36881-95.
22. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005; 52: 3110-24. (Pubitemid 41447092)
23. Ghoshal Gupta S, Baumann H, Wetzler M. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia. Leuk Res 2008; 32: 1005-14.
24. Evans MK, Yu C-R, Lohani A, Mahdi RM, Liu X, Trzeciak AR, et al. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene 2007; 26: 1941-8. (Pubitemid 46474639)
25. Anderson P, Sundstedt A, Li L, O'Neill EJ, Li S, Wraith DC, et al. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells. Int Immunol 2003;15: 1309-17. (Pubitemid 37369324)
26. Palmer DC, Restifo NP. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 2009; 30: 592-602.
27. Lovibond AC, Haque SJ, Chambers TJ, Fox SW. TGF-induced SOCS3 expression augments TNF-induced osteoclast formation. Biochem Biophys Res Commun 2003; 309: 762-7.
28. Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, et al. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999; 94: 2880-9. (Pubitemid 29477317)
29. Qasimi P, Ming-Lum A, Ghanipour A, Ong CJ, Cox ME, Ihle J, et al. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor - and nitric oxide production by macrophages. J Biol Chem 2006; 281: 6316-24. (Pubitemid 43847563)
30. Iannone F, De Bari C, Dell'Accio F, Covelli M, Cantatore FP, Patella V, et al. Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol 2001; 19: 139-45. (Pubitemid 32377162)
31. Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, et al. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 2001; 108: 1459-67. (Pubitemid 33091983)
32. Helmark IC, Mikkelsen UR, Borglum J, Rothe A, Petersen MC, Andersen O, et al. Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res Ther 2010; 12:R126.
33. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003; 4: 551-6. (Pubitemid 36701338)
34. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118: 205-16.
35. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, et al. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007; 56: 2957-67. (Pubitemid 47502742)
36. Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006; 54: 2152-63. (Pubitemid 44051072)
37. Yoshimura A, Nishinakamura A, Matsumura Y, Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005; 7: 100-10. (Pubitemid 40775170)
38. Van de Loo FA, Arntz OJ, Van Den Berg WB. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine 1997; 9: 453-62. (Pubitemid 27312246)
39. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
40. Greisberg J, Bliss M, Terek R. The prevalence of nitric oxide in apoptotic chondrocytes of osteoarthritis. Osteoarthritis Cartilage 2002; 10: 207-11. (Pubitemid 34189570)
41. Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, et al. Toll-like receptors and chondrocytes: the lipopolysaccharideinduced decrease in cartilage matrix synthesis is dependent on the presence of Toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum 2007; 56: 1880-93. (Pubitemid 47110387)
42. Schulze-Tanzil G. Activation and dedifferentiation of chondrocytes: implications in cartilage injury and repair. Ann Anat 2009; 191:325-38.
43. Badger AM, Roshak AK, Cook MN, Newman-Tarr TM, Swift BA, Carlson K, et al. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage 2000; 8: 434-43. (Pubitemid 32000967)
44. Frobose H, Ronn SG, Heding PE, Mendoza H, Cohen P, Mandrup-Poulsen T, et al. Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 2006; 20: 1587-96. (Pubitemid 43967566)
45. Joosten LA, Schalkwijk J, Van Den Berg WB, van de Putte LB. Chondrocyte unresponsiveness to insulin-like growth factor-1: a novel pathogenetic mechanism for cartilage destruction in experimental arthritis. Agents Actions 1989; 26: 193-5. (Pubitemid 19034652)
46. Dey BR, Furlanetto RW, Nissley P. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun 2000; 278: 38-43.
47. Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24: 5434-46. (Pubitemid 38738176)
48. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002; 277: 42394-8. (Pubitemid 35257562)
49. Zeng B, Li H, Liu Y, Zhang Z, Zhang Y, Yang R. Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2. Cancer Res 2008; 68: 5397-404.
50. Platanias LC, Uddin S, Yetter A, Sun XJ, White MF. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem 1996; 271: 278-82. (Pubitemid 26026590)
51. Burfoot MS, Rogers NC, Watling D, Smith JM, Pons S, Paonessaw G, et al. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem 1997; 272: 24183-90. (Pubitemid 27418617)
52. Kamezaki K, Shimoda K, Numata A, Matsuda T, Nakayama K, Harada M. The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals. Int Immunol 2004; 16: 1173-9. (Pubitemid 39136734)
53. Karaghiosoff M, Neubauer H, Lassnig C, Kovarik P, Schindler H, Pircher H, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 2000; 13: 549-60.